All News

A new viewpoint in JAMA has proposed a way to make it safe for undocumented immigrants to get care: sanctuary hospitals.

Results of the Phase 3 ARROW trial revealed that patiehts with refractory multiple myeloma can live up to 3.6 months longer, without their disease worsening, when Kyprolis (carfilzomib) is administered once-weekly at the 70 mg/m2 dose with dexamethasone rather than Kyprolis administered twice-weekly at the 27 mg/m2 dose with dexamethasone, according to Amgen.

Hydromorphone is commonly used in hospital emergency rooms to treat patients with migraines; however, the drug is less effective than the drug prochlorperazine used with diphenhydramine, according to research.

Physicians should be cautious when treating patients with lung cancer after progression on nivolumab because nivolumab-refractory lung cancer could have a significant response to salvage chemotherapy, according to a new study.

The rule has several proposals that may be attractive to insurers in the area of risk adjustment.

Authors from a working group of the American Diabetes Association and the European Association for the Study of Diabetes made recommendations that could lead to broader use of technology. CGM systems are poised to make advances that could make them more useful to the larger group of patients with type 2 diabetes.

This week, the top managed care news included a judge ruling President Donald Trump can end the cost-sharing reduction subsidies; findings on awareness of the Choosing Wisely campaign; and conference coverage from around the nation.

A newly published paper seeks to better explore the experiences of men with rheumatoid arthritis in the context of their lives, their masculine identity, and their ability to cope with the disease.

Coverage of our peer-reviewed research and news reporting in the healthcare and mainstream press.

Top news of the day: More people will have access to ACA plans with no premiums, a challenge to Arizona's Medicaid expansion funding goes to the state supreme court, and a dive into coverage of the opioid epidemic.

At more than $200 per share bid, CVS Health is reportedly in negotiations to buy the health insurance giant Aetna.

Sponsors of the survey want to draw attention to the mental health aspects of living with condition, which causes the immune system to overreact.

Many of survivors of childhood cancer who are now within the prime age for labor force participation are reluctant to make changes in their employment because of access to health insurance, and therefore, job lock is common among this population.

While Congress debates the fate of the Affordable Care Act, healthcare transformation continues, as seen in an update released this week at Horizon Blue Cross Blue Shield of New Jersey.

The subsidies allow insurers to hold down overall premiums under the Affordable Care Act.

A new study found that patients with borderline pulmonary hypertension (mPAP values of 19 to 24 mm Hg) should be considered an at-risk subgroup with increased mortality compared with patients with lower mean pulmonary arterial pressures.

After a study reported that physicians who authored dermatology clinical guidelines didn't always fully disclose financial conflicts of interest, the American Academy of Dermatology urged the public to view the findings with caution.

New high-risk groups of patients with chronic obstructive pulmonary disease according to GOLD 2017 were found to have more characteristics related to acute exacerbation and mortality risks.

Results of the first annual National Cancer Opinion Survey, established by the American Society of Clinical Oncology (ASCO), show that the majority of Americans are unaware of several key risk factors for cancer, and that a minority are taking active steps to reduce their personal risk.

Implementing the Bipartisan Health Care Stabilization Act of 2017 crafted by Senators Lamar Alexander, R-Tennessee, and Patty Murray, D-Washington, to stabilize the Affordable Care Act's individual insurance markets would reduce the federal deficit by $3.8 billion over 10 years, according to an estimate from the Congressional Budget Office and the Joint Committee on Taxation.

Researchers developed additional guidance for using granulocyte colony-stimulating factors to optimize pegfilgrastim use in clinical practices for patients at risk of chemotherapy-induced febrile neutropenia.

In addition to the cost, the excessive overuse of laboratory testing causes patient discomfort and can lead to hospital-acquired anemia, which results in additional testing, prolonged hospitalizations, unnecessary transfusions, and increased mortality for patients with cardiopulmonary diseases.

With biosimilars being an everyday headline, Jason Bernstein, Epocrates Lead Strategist, outlined key reasons for pharma's growing interest in biosimilar development and key differences between generics and biosimilars.

Researchers find that the most common explanation for cognitive symptoms that resemble attention-deficit/hyperactivity disorder is substance abuse.